Fog 36°
Tag:

Immunocompromised Individuals

News
Nationwide Recall Issued For Brand Of Eye Drops Over Contamination Risk Nationwide Recall Issued For Brand Of Eye Drops Over Contamination Risk
Nationwide Recall Issued For Brand Of Eye Drops Over Contamination Risk A nationwide recall has been issued for a specific lot of eye drops due to potential fungal contamination, which could cause serious eye infections. The recall involves lubricant eye drops under the Systane brand, manufactured by Alcon Laboratories, following a report of fungal material found in a sealed vial.  No illnesses have been reported, but fungal contamination can pose vision-threatening risks and, in rare cases, life-threatening complications for immunocompromised individuals. Details of the recall: Specific brand: Systane Lubricant Eye Drops Ultra PF, Single Vials On-…

SHARE

by Joe Lombardi
News
COVID-19: Health Department Urges NYers To Get Vaccine As Respiratory Illness Season Starts COVID-19: Health Department Urges NYers To Get Vaccine As Respiratory Illness Season Starts
Covid-19: Health Department Urges NYers To Get Vaccine As Respiratory Illness Season Starts With respiratory illness season underway, the New York State Department of Health is actively urging residents aged 6 months and older to get the latest COVID-19 vaccine.  This recommendation aligns with the Centers for Disease Control and Prevention (CDC) recent update, which emphasizes the importance of a second dose of the 2024-2025 vaccine for older adults and those at higher risk. The CDC now advises that adults aged 65 and older, along with individuals who are moderately or severely immunocompromised, should receive a second dose six months after their initial vaccination. This u…

SHARE

by Joe Lombardi
News
COVID-19: FDA Expected To Authorize Booster Shots For Immunocompromised People COVID-19: FDA Expected To Authorize Booster Shots For Immunocompromised People
Covid-19: FDA Expected To Authorize Booster Shots For Immunocompromised People The US Food and Drug Administration is expected to move forward quickly with authorization of COVID-19 booster shots for some Americans who are immunocompromised, according to reports. Health officials said that the third shot of the current two-dose Pfizer and Moderna vaccine could be authorized within the next 48 hours, though no official timetable has been set as variants of the virus and COVID-19 mutations continue to cause a surge in new cases. Before a vaccine can be used in new ways outside existing authorization it requires new approval from the FDA. Currently, the Moderna, Pfizer…

SHARE

by Zak Failla